Pharmaxis is Pharmaceuticals in Australia that focus on liver fibrosis business. Founded in 1998. They cover business area such as Pharmaxis Ltd, development, commercialization, human healthcare product, management, fibrotic and inflammatory disease, drug, inflammatory and fibrotic disease, nash, pulmonary fibrosis, kidney, liver, cancer, its amine oxidase inhibitor chemistry platform, its product pipeline, Orbital, Mannitol business, New Drug Development.
1998
( 26 years old in 2024 )
Liver Fibrosis
-
Locked Bag 5015
Frenchs Forest, New South Wales 2086
Australia
Private
Pharmaxis Ltddevelopmentcommercializationhuman healthcare productmanagementfibrotic and inflammatory diseasedruginflammatory and fibrotic diseasenashpulmonary fibrosiskidneylivercancerits amine oxidase inhibitor chemistry platformits product pipelineOrbitalMannitol businessNew Drug Development
* We use standard office opening hours in near Pharmaxis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pharmaxis is Pharmaceuticals business from Australia that founded in 1998 (26 years old in 2024), Pharmaxis business is focusing on Liver Fibrosis.
Pharmaxis headquarter office and corporate office address is located in Locked Bag 5015 Frenchs Forest, New South Wales 2086 Australia.
Pharmaxis was founded in Australia.
In 2024, Pharmaxis is currently focus on liver fibrosis sector.
Above is snippet of Google Trends for "liver fibrosis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pharmaxis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
